Dr. Pietanza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2000
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2004 - 2007
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
- State University of New York Downstate Medical Center College of MedicineClass of 2001
Certifications & Licensure
- NY State Medical License 2004 - 2025
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2014
Clinical Trials
- Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer Start of enrollment: 2008 Aug 01
- Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment Start of enrollment: 2008 Dec 01
- Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- 353 citationsRovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 studyCharles M. Rudin, M. Catherine Pietanza, Todd M. Bauer, Neal Ready, Daniel Morgensztern
The Lancet. Oncology. 2017-01-01 - 397 citationsA DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivoLaura Saunders, Alexander J. Bankovich, Wade C. Anderson, Monette Aujay, Sheila Bheddah
Science Translational Medicine. 2015-08-26 - 224 citationsPemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNO...Delvys Rodriguez-Abreu, Steven Francis Powell, Maximilian Hochmair, Shirish M. Gadgeel, Emilio Esteban
Annals of Oncology. 2021-07-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: